SK12297A3 - Benzoxazoles, pyridine derivatives, process for producing same pharmaceutical composition containing them, their use and intermediate product - Google Patents

Benzoxazoles, pyridine derivatives, process for producing same pharmaceutical composition containing them, their use and intermediate product Download PDF

Info

Publication number
SK12297A3
SK12297A3 SK122-97A SK12297A SK12297A3 SK 12297 A3 SK12297 A3 SK 12297A3 SK 12297 A SK12297 A SK 12297A SK 12297 A3 SK12297 A3 SK 12297A3
Authority
SK
Slovakia
Prior art keywords
pharmaceutically acceptable
formula
compound
acceptable salt
benzoxazolyl
Prior art date
Application number
SK122-97A
Other languages
English (en)
Slovak (sk)
Inventor
David Haigh
Harshad K Rami
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9415330A external-priority patent/GB9415330D0/en
Priority claimed from GBGB9425599.9A external-priority patent/GB9425599D0/en
Priority claimed from GBGB9509923.0A external-priority patent/GB9509923D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of SK12297A3 publication Critical patent/SK12297A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
SK122-97A 1994-07-29 1995-07-28 Benzoxazoles, pyridine derivatives, process for producing same pharmaceutical composition containing them, their use and intermediate product SK12297A3 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB9415330A GB9415330D0 (en) 1994-07-29 1994-07-29 Novel compounds
GBGB9425599.9A GB9425599D0 (en) 1994-12-19 1994-12-19 Novel compounds
GBGB9509923.0A GB9509923D0 (en) 1995-05-17 1995-05-17 Novel compounds
PCT/EP1995/003038 WO1996004260A1 (fr) 1994-07-29 1995-07-28 Benzoxazoles et derives de pyridine utiles dans le traitement du diabete de type ii

Publications (1)

Publication Number Publication Date
SK12297A3 true SK12297A3 (en) 1997-08-06

Family

ID=27267309

Family Applications (1)

Application Number Title Priority Date Filing Date
SK122-97A SK12297A3 (en) 1994-07-29 1995-07-28 Benzoxazoles, pyridine derivatives, process for producing same pharmaceutical composition containing them, their use and intermediate product

Country Status (16)

Country Link
EP (1) EP0772605A1 (fr)
AP (1) AP776A (fr)
BR (1) BR9508468A (fr)
CA (1) CA2196079A1 (fr)
CZ (1) CZ25497A3 (fr)
DZ (1) DZ1916A1 (fr)
FI (1) FI970357A (fr)
HU (1) HUT76637A (fr)
IL (3) IL114759A (fr)
MA (1) MA23632A1 (fr)
MX (1) MX9700763A (fr)
NO (1) NO307827B1 (fr)
OA (1) OA10470A (fr)
PL (1) PL318766A1 (fr)
SK (1) SK12297A3 (fr)
WO (2) WO1996004261A1 (fr)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9600464D0 (en) * 1996-01-09 1996-03-13 Smithkline Beecham Plc Novel method
DK0916651T3 (da) * 1996-04-04 2003-12-01 Sankyo Co Phenylalkylcarboxylsyrederivater
US6090839A (en) * 1996-12-23 2000-07-18 Merck & Co., Inc. Antidiabetic agents
US6160000A (en) * 1996-12-23 2000-12-12 Merck & Co., Inc. Antidiabetic agents based on aryl and heteroarylacetic acids
IL135177A0 (en) 1997-10-02 2001-05-20 Sankyo Co Amidocarboxylic acid derivatives and pharmaceutical compositions containing the same
US6444816B1 (en) 1997-10-27 2002-09-03 Dr. Reddy's Research Foundation Fused 7-oxo-pyrimidinyl compounds, preparation, composition and use thereof
MXPA00004036A (es) 1997-10-27 2006-05-24 Reddys Lab Ltd Dr Compuestos triciclicos novedosos y su uso en medicina; proceso para su preparacion y composiciones farmaceuticas que los contienen..
US6440961B1 (en) 1997-10-27 2002-08-27 Dr. Reddy's Research Foundation Tricyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them
WO1999019313A1 (fr) * 1997-10-27 1999-04-22 Dr. Reddy's Research Foundation Nouveaux composes tricycliques et leur utilisation en medecine, procede de preparation de ces derniers et compositions pharmaceutiques les contenant
CN1280574A (zh) * 1997-10-27 2001-01-17 雷迪研究基金会 新的杂环化合物及其在医药中的应用、它们的制备方法和含有它们的药物组合物
US6369067B1 (en) 1997-10-27 2002-04-09 Dr. Reddy's Research Foundation Monocyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them
US6265401B1 (en) 1997-10-27 2001-07-24 Reddy-Cheminor, Inc. Bicyclic compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them
CA2307068C (fr) 1997-10-27 2007-04-10 Dr. Reddy's Research Foundation Composes bicycliques, procede de preparation et compositions pharmaceutiques les contenant
NZ504106A (en) * 1998-05-27 2003-02-28 Dr Fused Oxazine, Thiazine and pipyridine compounds, process for their preparation and pharmaceutical compositions containing them
EP1113801A4 (fr) 1998-09-17 2002-10-02 Bristol Myers Squibb Co PROCEDE POUR TRAITER L'ATHEROSCLEROSE AU MOYEN D'UN INHIBITEUR D'aP2 OU D'UNE COMBINAISON CORRESPONDANTE
JP2002527516A (ja) * 1998-10-21 2002-08-27 ノボ ノルディスク アクティーゼルスカブ 新規化合物、それらの製造及び使用
JP2002527501A (ja) 1998-10-21 2002-08-27 ノボ ノルディスク アクティーゼルスカブ 新規化合物、その製造及び利用
AU6325799A (en) * 1998-10-21 2000-05-08 Dr. Reddy's Research Foundation New compounds, their preparation and use
EP1123279A1 (fr) * 1998-10-21 2001-08-16 Novo Nordisk A/S Nouveaux composes, preparation et utilisation correspondantes
US6300339B1 (en) 1998-10-21 2001-10-09 Novo Nordisk A/S Compounds, their preparation and use
AU6325899A (en) * 1998-10-21 2000-05-08 Dr. Reddy's Research Foundation New compounds, their preparation and use
US6214820B1 (en) 1998-10-21 2001-04-10 Novo Nordisk A/S Compounds, their preparation and use
US6365586B1 (en) 1998-10-21 2002-04-02 Novo Nordisk A/S Compounds, their preparation and use
EP1123268A1 (fr) * 1998-10-21 2001-08-16 Novo Nordisk A/S Nouveaux composes, leur preparation et leur utilisation
US6468996B1 (en) 1998-10-21 2002-10-22 Novo Nordisk A/S Substituted hetero-polycyclic compounds as PPARα and PPARγ activators
US6248781B1 (en) 1998-10-21 2001-06-19 Novo Nordisk A/S Compounds useful in the treatment of conditions mediated by peroxisome proliferator-activated receptors (PPAR)
CN1323300A (zh) * 1998-10-29 2001-11-21 雷迪研究基金会 制备新的抗糖尿病剂的改进方法
US6531596B1 (en) 1998-10-29 2003-03-11 Dr. Reddy's Laboratories Ltd. Process for the preparation of new antidiabetic agents
WO2000063189A1 (fr) * 1999-04-16 2000-10-26 Novo Nordisk A/S Formes cristallines de r-guanidines, d'arginine ou de (l)-arginine (2s-2-ethoxy-3-{4-[2-(10h-phenoxazin-10-yl)ethoxy]phenyl}propanoate
WO2000063209A1 (fr) * 1999-04-20 2000-10-26 Novo Nordisk A/S Nouveaux composes, preparation et utilisation associees
US6972294B1 (en) 1999-04-20 2005-12-06 Novo Nordisk, A/S Compounds, their preparation and use
KR20020005703A (ko) * 1999-04-20 2002-01-17 한센 핀 베네드, 안네 제헤르, 웨이콥 마리안느 신규한 화합물, 그의 제법 및 용도
EP1171431A1 (fr) * 1999-04-20 2002-01-16 Novo Nordisk A/S Composes, leur preparation et utilisation
US6274608B1 (en) 1999-04-20 2001-08-14 Novo Nordisk A/S Compounds, their preparation and use
US6369055B1 (en) 1999-04-20 2002-04-09 Novo Nordisk A/S Compounds, their preparation and use
US7414128B2 (en) 1999-04-20 2008-08-19 Dr. Reddy's Laboratories, Limited Crystalline R-guanidines, Arginine or (L)-Arginine (2S)-2-Ethoxy-3-{4-[2-(10H -phenoxazin-10-yl)ethoxy]phenyl}propanoate
KR100610578B1 (ko) 1999-04-28 2006-08-09 닥터 레디스 레보러터리즈 리미티드 치환된 이원 헤테로고리, 비만증 및 고콜레스테롤증치료제로서의 그 용도
CA2382966A1 (fr) 1999-08-27 2001-03-08 Eli Lilly And Company Derives de biaryl-oxa(thia)zole et leur utilisation en tant que modulateurs de ppar
HU230609B1 (hu) * 2000-01-19 2017-03-28 Cadila Healthcare Ltd. Hipolipidémiás és hipokoleszterinémiás hatású szubsztituált pirrolszármazékok, azokat tartalmazó gyógyszerkészítmények, eljárás előállításukra, köztitermékek és alkalmazásuk
WO2001055086A1 (fr) * 2000-01-28 2001-08-02 Novo Nordisk A/S Derives d'acide propionique a substitution alkynyle et leur utilisation pour lutter contre le diabete et l'obesite
US6555577B1 (en) 2000-01-28 2003-04-29 Novo Nordisk A/S Compounds, their preparation and use
US6569901B2 (en) 2000-01-28 2003-05-27 Novo Nordisk A/S Alkynyl-substituted propionic acid derivatives, their preparation and use
US6509374B2 (en) 2000-04-17 2003-01-21 Novo Nordisk A/S Compounds, their preparation and use
US6908908B2 (en) 2000-05-12 2005-06-21 Ortho-Mcneil Pharmaceutical, Inc. Biologically active 4H-benzo [1,4] oxazin-3-ones
WO2001087860A2 (fr) * 2000-05-12 2001-11-22 Ortho-Mcneil Pharmaceutical, Inc. Nouveaux benzoxazinones utilises comme modulateurs du recepteur gamma active de la proliferation des peroxysomes, et methode de traitement associee
EP1280783A2 (fr) * 2000-05-12 2003-02-05 Ortho-McNeil Pharmaceutical, Inc. Methodes de traitement mettant en oeuvre des benzoxazinones comme modulateurs du recepteur gamma active par le proliferateur du peroxisome
PT1280784E (pt) * 2000-05-12 2007-09-03 Ortho Mcneil Pharm Inc 4h-benzo [1,4] oxazin-3-onas biologicamente activas.
US6987123B2 (en) * 2001-07-26 2006-01-17 Cadila Healthcare Limited Heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine
US7067530B2 (en) 2001-07-30 2006-06-27 Novo Nordisk A/S Compounds, their preparation and use
US6869967B2 (en) 2001-07-30 2005-03-22 Novo Nordisk A/S Peroxisome proliferator-activated receptor (PPAR) active vinyl carboxylic acid derivatives
US7220877B2 (en) 2001-10-17 2007-05-22 Novo Nordisk A/S Compounds, their preparation and use
JP2005518408A (ja) 2001-12-29 2005-06-23 ノボ　ノルディスク　アクティーゼルスカブ 異常脂肪血症を治療するための、ｇｌｐ−１化合物と他の薬物との組み合わせ使用
US7015345B2 (en) 2002-02-21 2006-03-21 Asahi Kasei Pharma Corporation Propionic acid derivatives
US7816385B2 (en) 2002-12-20 2010-10-19 High Point Pharmaceuticals, Llc Dimeric dicarboxylic acid derivatives, their preparation and use
US6653334B1 (en) 2002-12-27 2003-11-25 Kowa Co., Ltd. Benzoxazole compound and pharmaceutical composition containing the same
EP2154131A4 (fr) * 2007-04-26 2011-09-21 Pharmafrontier Co Ltd Inhibiteur du récepteur couplé à protéine g et produit pharmaceutique
WO2012104869A1 (fr) 2011-01-31 2012-08-09 Cadila Healthcare Limited Traitement de la lipodystrophie
KR101617812B1 (ko) 2013-04-22 2016-05-03 카딜라 핼쓰캐어 리미티드 비알콜성 지방간 질환을 위한 신규 조성물
US20160107989A1 (en) 2013-05-30 2016-04-21 Cadila Healthcare Limited A process for preparation of pyrroles having hypolipidemic hypocholesteremic activities
TW201513857A (zh) 2013-07-05 2015-04-16 Cadila Healthcare Ltd 協同性組成物
IN2013MU02470A (fr) 2013-07-25 2015-06-26 Cadila Healthcare Ltd
US10112898B2 (en) 2013-09-06 2018-10-30 Cadila Healthcare Limited Process for the preparation of saroglitazar pharmaceutical salts
WO2017064635A2 (fr) 2015-10-14 2017-04-20 Cadila Healthcare Limited Composé pyrrole, compositions et procédé de préparation associé
JP6840853B2 (ja) 2016-12-09 2021-03-10 カディラ・ヘルスケア・リミテッド 原発性胆汁性胆管炎の治療

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5089514A (en) * 1990-06-14 1992-02-18 Pfizer Inc. 3-coxazolyl [phenyl, chromanyl or benzofuranyl]-2-hydroxypropionic acid derivatives and analogs as hypoglycemic agents
SK695A3 (en) * 1992-07-03 1995-07-11 Smithkline Beecham Plc Heterocyclic compounds method of their production and using

Also Published As

Publication number Publication date
IL125525A0 (en) 1999-03-12
HUT76637A (en) 1997-10-28
IL114759A (en) 1999-10-28
WO1996004261A1 (fr) 1996-02-15
MA23632A1 (fr) 1996-04-01
NO970373L (no) 1997-03-18
NO970373D0 (no) 1997-01-28
WO1996004260A1 (fr) 1996-02-15
EP0772605A1 (fr) 1997-05-14
OA10470A (en) 2002-04-08
IL114759A0 (en) 1995-12-31
MX9700763A (es) 1997-05-31
DZ1916A1 (fr) 2002-02-17
CA2196079A1 (fr) 1996-02-15
CZ25497A3 (en) 1997-09-17
NO307827B1 (no) 2000-06-05
IL125525A (en) 2000-02-29
FI970357A0 (fi) 1997-01-28
FI970357A (fi) 1997-03-26
AP9700918A0 (en) 1997-01-31
AP776A (en) 1999-10-28
PL318766A1 (en) 1997-07-07
BR9508468A (pt) 1997-11-25

Similar Documents

Publication Publication Date Title
SK12297A3 (en) Benzoxazoles, pyridine derivatives, process for producing same pharmaceutical composition containing them, their use and intermediate product
DE69403823T2 (de) Substituierte Phenylsulfonamine als selektive B3-Agonisten zur Behandlung von Diabetes und Fettleibigkeit
JP4229701B2 (ja) β−ラクタム化合物及びその製造方法並びにこれを含有する血清コレステロール低下剤
DE69220258T2 (de) Azabicyclische Verbindungen, diese enthaltende pharmazeutische Zubereitungen und ihre therapeutische Verwendung
RU2133743C1 (ru) Производные оксазолидин-2-она и лекарственное средство на их основе
DE60107820T2 (de) Neue verwendung von phenylheteroalkylamin-derivaten
KR19990077099A (ko) 증후군 x의 치료를 위한 ppar-알파 및 ppar-감마 길항제의 용도
WO1994013650A1 (fr) Derives heterocycliques et leur utilisation comme produits pharmaceutiques
KR20060010770A (ko) 아제티딘카르복스아미드 유도체와 씨비1 수용체로 매개된질병의 치료에 대한 이들의 용도
CA2310627C (fr) Composes ether cycliques du type piperidinylaminomethyltrifluoromethyle em tant qu'antagonistes de la substance p
EP4329877A1 (fr) Composés macrocycliques d'amide substitués ayant une activité agoniste du récepteur de l'orexine 2
WO1998021185A1 (fr) Arylurees ou derives d'arylmethylcarbamyle
JPH03101643A (ja) ハロゲノアルキルフェニルアルコール、ケトンおよびそれらの水和物
EP4186891A1 (fr) Dérivé de benzimidazole substitué et son utilisation
DE60103033T2 (de) Neue phenylheteroalkylamin-derivate
JPH064604B2 (ja) モルホリン誘導体，それらの製法及びそれらを含有する医薬組成物
CS159192A3 (en) 2-hydroxy-2-phenylethylamino derivatives, process of their preparation andtheir use
JPH03193747A (ja) ２―ヒドロキシ―３―フエノキシプロピルアミノ化合物、該化合物を含有する肥満症及び類縁症状の治療用薬剤学的組成物、該化合物の製造方法、及び中間体
EP1165528B1 (fr) Nouveaux derives de morpholine, procede pour leur preparation et compositions pharmaceutiques les contenant
JPH03169841A (ja) アミノプロパノール誘導体およびそれを含有する薬剤組成物、ならびにそれらの製造方法
HRP20010566A2 (en) (1-phenacy-3-phenyl-3-piperidylethyl)piperidine derivatives, method for the production thereof and pharmaceutical compositions containing the same
AU697545B2 (en) Benzoxazoles and pyridine derivatives useful in the treatment of the ty pe II diabetes
JPH0347165A (ja) ピロールカルボン酸誘導体
JP3048643B2 (ja) ５，７−ジヒドロ−３−［２−｛１−ベンジルピペリジン−４−イル｝エチル］−６Ｈ−ピロロ−［４，５−ｆ］−１，２−ベンズイソオキサゾール−６−オンの製造方法及び中間体
JP3113447B2 (ja) アミノカルボン酸誘導体、その製造方法および用途